7.425
Schlusskurs vom Vortag:
$7.23
Offen:
$7.16
24-Stunden-Volumen:
18,814
Relative Volume:
0.09
Marktkapitalisierung:
$690.99M
Einnahmen:
$106.66M
Nettoeinkommen (Verlust:
$15.16M
KGV:
79.41
EPS:
0.0935
Netto-Cashflow:
$6.37M
1W Leistung:
+0.20%
1M Leistung:
-4.44%
6M Leistung:
-29.95%
1J Leistung:
-51.28%
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Firmenname
Gyre Therapeutics Inc
Sektor
Branche
Telefon
(619) 949-3681
Adresse
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Vergleichen Sie GYRE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
GYRE
Gyre Therapeutics Inc
|
7.37 | 649.10M | 106.66M | 15.16M | 6.37M | 0.0935 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.48 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.19 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.25 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.21 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.50 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-11 | Eingeleitet | Noble Capital Markets | Outperform |
2021-04-29 | Fortgesetzt | Stephens | Overweight |
2021-02-10 | Eingeleitet | Piper Sandler | Overweight |
2020-05-21 | Eingeleitet | Raymond James | Outperform |
2019-01-04 | Eingeleitet | Oppenheimer | Outperform |
2018-02-12 | Bestätigt | B. Riley FBR, Inc. | Buy |
2018-02-09 | Bestätigt | Chardan Capital Markets | Buy |
2017-12-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
2017-06-12 | Eingeleitet | Chardan Capital Markets | Buy |
2017-06-06 | Eingeleitet | Ladenburg Thalmann | Buy |
2016-06-30 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten
What analysts say about Gyre Therapeutics Inc. stockExceptional profit velocity - Autocar Professional
Gyre Therapeutics Inc. Stock Analysis and ForecastHigh-yield capital appreciation - jammulinksnews.com
What drives Gyre Therapeutics Inc. stock priceOutperformance with explosive growth - jammulinksnews.com
Is GEOS a good long term investmentStrong return on assets - Autocar Professional
What drives LVRO stock priceFree Consultation - jammulinksnews.com
Published on: 2025-07-22 17:00:56 - jammulinksnews.com
What drives UWMC.WS stock priceSuperior investment outcomes - jammulinksnews.com
Best Stocks for Dividend Growth in India Trusted Investment GroupFree Market Dynamics Reports - Autocar Professional
Stocks with the Best Technical Indicators in India Intelligent Investment DecisionsExceptional earning trajectories - PrintWeekIndia
Is LCUT a good long term investmentRemarkably fast returns - PrintWeekIndia
Can Confidence Petroleum India Limited (526829) Maintain Its ValuationFree Stock Market Beginners Guide - PrintWeekIndia
What drives Delta Air Lines Inc. stock priceHigh-velocity capital appreciation - Autocar Professional
D India Limited (522275) Sees Unusual Trading VolumeSuperior returns - jammulinksnews.com
Best Real Estate Stocks AI Driven Market StrategiesFree Consultation - jammulinksnews.com
Is Gyre Therapeutics Inc. a good long term investmentOver 200% growth - jammulinksnews.com
Will Gyre Therapeutics Inc. stock benefit from AI tech trendsFree Professional Trading Signals - Newser
Will ADSEW stock benefit from AI tech trendsTop Momentum Stock Pick - Newser
Why Gyre Therapeutics Inc. stock attracts strong analyst attentionFree Day Trading Recommendations - beatles.ru
What makes USCB stock price move sharplyFree Stock Market Query - Newser
What makes AerCap Holdings N.V. stock price move sharplyFast Moving Stock Alerts - Newser
What makes Gyre Therapeutics Inc. stock price move sharplyLong Term Secure Gain Stocks - Newser
What makes AMTD Digital Inc. Depositary Receipt stock price move sharplyPortfolio Boosting Stock Alerts - Newser
How Weyco Group Inc. stock performs during market volatilityWatchlist Winner Update - Newser
Why CO2 Energy Transition Corp. stock attracts strong analyst attentionEarly Buy Suggestion - Newser
How Gyre Therapeutics Inc. stock performs during market volatilityInstant Stock Updates - Newser
How 4D Molecular Therapeutics Inc. stock performs during market volatilityFree Stock Market Forecasting Tools - Newser
How ASB.PRF stock performs during market volatilityElite Investor Club - Newser
What makes ABCL stock price move sharplySolid Return Trade Selections - Newser
How High Can LDO(lidodaotoken) GoFree VIP Group - Newser
Head to Head Analysis: Gyre Therapeutics (NASDAQ:GYRE) versus Entera Bio (NASDAQ:ENTX) - Defense World
Gyre Therapeutics, Inc.(NasdaqCM: GYRE) dropped from Russell 3000 Value Index - MarketScreener
Gyre Therapeutics, Inc. (GYRE) Raises $23M in Public Stock Offering to Fund Liver Fibrosis Trials - MSN
Gyre Therapeutics announces first doing in Phase 1 trial of F230 - TipRanks
Gyre Therapeutics (GYRE) Begins Phase 1 Trial for Pulmonary Hypertension Drug | GYRE Stock News - GuruFocus
Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Gyre Therapeutics Inc-Aktie (GYRE) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Ma Songjiang | President |
May 28 '25 |
Sale |
10.07 |
558 |
5,619 |
2,806,084 |
Ma Songjiang | President |
May 22 '25 |
Sale |
10.97 |
2,000 |
21,940 |
2,808,824 |
Ma Songjiang | President |
May 23 '25 |
Sale |
10.24 |
182 |
1,864 |
2,808,642 |
Ma Songjiang | President |
May 20 '25 |
Sale |
11.25 |
2,000 |
22,500 |
2,812,824 |
Ma Songjiang | President |
May 21 '25 |
Sale |
10.83 |
2,000 |
21,660 |
2,810,824 |
Ma Songjiang | President |
May 16 '25 |
Sale |
11.31 |
2,000 |
22,620 |
2,816,824 |
Ma Songjiang | President |
May 19 '25 |
Sale |
11.11 |
2,000 |
22,220 |
2,814,824 |
Ma Songjiang | President |
May 15 '25 |
Sale |
10.68 |
2,000 |
21,360 |
2,818,824 |
Ma Songjiang | President |
May 14 '25 |
Sale |
11.30 |
20 |
226 |
2,820,824 |
Ye Weiguo | Chief Operating Officer |
Apr 01 '25 |
Option Exercise |
0.75 |
50,000 |
37,500 |
700,000 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):